Table 2.

Data category by feedback measure and type of cancer

Data category	Type of guideline	n (%)
		Early breast	Advanced breast	Colorectal	Lung	Melanoma	Total
Category 1	Level of hospital	0 (0.0%)	0 (0.0%)	0 (0.0%)	1 (1.2%)	0 (0.0%)	1 (0.4%)
Population-based registry, routine-inpatient data	Surgery; guideline not reliant on clinical stage	0 (0.0%)	0 (0.0%)	0 (0.0%)	4 (4.8%)	3 (7.3%)	7 (2.9%)
	Sub-total	0 (0.0%)	0 (0.0%)	0 (0.0%)	5 (6.0%)	3 (7.3%)	8 (3.3%)
Category 2	Initial diagnostic or staging procedures	0 (0.0%)	0 (0.0%)	2 (4.3%)	14 (16.9%	3 (7.3%)	19 (7.8%)
Core clinical registry	Initial treatment in relation to clinical stage-at-diagnosis or performance status or specific prognostic features of the cancer	15 (60.0%)	10 (21.3%)	23 48.9%))	23 (27.7%))	25 (61.0%)	96 (39.5%)
	Participation in clinical trial	0 (0.0%)	0 (0.0%)	0 (0.0%)	2 (1.2%)	0 (0.0%)	2 (0.8%)
	Assessment by multi-disciplinary team;	0 (0.0%)	0 (0.0%)	0 (0.0%)	2 (1.2%)	0 (0.0%)	2 (0.8%)
	Sub-total	15 (60.0%)	10 (21.2%)	25 (53.2%)	41 (49.4%)	28 (68.3%)	119 (49.0%)
Category 3	Details of surgery;	0 (0.0%)	0 (0.0%)	10 (21.3%)	0 (0.0%)	0 (0.0%)	10 (4.1%)
Extended clinical registry medical record review,	Treatments for complications of cancer treatment	0 (0.0%)	3 (6.4%)	2 (4.3%)	1 (1.2%)	0 (0.0%)	6 (2.5%)
	Long-term follow-up;	1 (4.0%)	3 (6.4%)	3 (6.4%)	2 (2.4%)	4 (9.8%)	13 (5.3%)
	Management of disease progression including pain relief and palliation	2 (8.0%)	22 (46.8%)	6 (12.8%)	29 (34.9%)	0 (0.0%)	59 (24.3%)
	Sub-total	3 (12.0%)	28 (59.6%)	21 (44.9%)	32 (38.6%)	4 (9.8%)	88 (36.1%)
Category 4	Communication and information sharing between clinician and patient	7 (28.0%)	9 (19.1%)	1 (2.1%)	5 (6.0%)	6 (14.6%)	28 (11.5%)
Patient interview, audio-taping of consultation
	Grand total	25 (100%)	47 (100%)	47 (100%)	83 (100%)	41 (100%)	243 (100%)